AHEAD Medicine receives an award from Taiwan's National Development Council in recognition of its AI-powered healthcare technology and contributions to the medical field. The award recognizes the company's work in healthcare technology, specifically its use of artificial intelligence.
Andrea Wang, CEO and co-founder of AHEAD Medicine, has been selected for the ISAC Leadership Development Program as an International Innovator. The selection recognizes her leadership in healthcare AI innovation.
AHEAD Medicine unveils an automated AML diagnosis solution powered by Cyto-Copilot. The solution supports classification across five different flow cytometry test panels, offering a panel-agnostic approach to AML diagnosis.
AHEAD Medicine was accepted into Berkeley SkyDeck’s Global Innovation Partner program, a three-month incubator. The program helped the startup use AI to advance blood cancer diagnosis.
